IPP Bureau
Glenmark launches novel fixed-dose combination for diabetes
By IPP Bureau - October 26, 2021
It is the first company to launch Remogliflozin, Vildagliptin and Metformin combination
GenWorks Heath to distribute PerkinElmer’s newborn and prenatal screening products
By IPP Bureau - October 26, 2021
Collaboration designed to bring reproductive health screening capabilities to hospitals and clinics across the country
Healthium Medtech introduces surgical wound dressing product
By IPP Bureau - October 26, 2021
Expands wound care portfolio and aims to drive greater market penetration and availability in the wound dressing category
10x Genomics opens Singapore manufacturing hub
By IPP Bureau - October 26, 2021
Strengthens supply chain continuity with first manufacturing facility outside of the U.S.
Biocon reports a consolidated net profit of Rs. 138.3 crore in Q2FY22
By IPP Bureau - October 25, 2021
The Research Services and Biosimilars business segments reported a growth of 17% and 10%, respectively
Lupin enters Guinness Records highlights rise in strokes
By IPP Bureau - October 25, 2021
This unique record was made possible by collating hard copies of the books in a structured manner
Biocon Q2FY22 in line with estimates, better margins: ICICI Direct
By IPP Bureau - October 25, 2021
Key takeaways of recent quarter & conference call highlights
Syngene reports better than expected revenues, margin pressure in Q1FY22: ICICI Direct
By IPP Bureau - October 25, 2021
Key takeaways of recent quarter & conference call highlights
Roche’s Susvimo, for `wet’ age-related macular degeneration (nAMD) approved
By IPP Bureau - October 25, 2021
The implant is surgically inserted into the eye during a one-time, outpatient procedure and refilled every six months
India ramps up medical education with substantial investments
By IPP Bureau - October 25, 2021
A total of Rs 17,691.08 cr. invested in 157 new approved medical colleges since 2014
QurHealth launch patient care concierge programme in India
By IPP Bureau - October 25, 2021
With the launch of QurOne, the brand aims to redefine healthcare in the country with seamless, hassle-free patient care and hyper-coordinated workflows
Novartis cancer drug trial does not meet primary end points
By IPP Bureau - October 25, 2021
The company is continuing with the evaluation of canakinumab in lung cancer, and is applying findings to the overall lung cancer development plan
WuXi ATU opens manufacturing facility in Shanghai to enhance its CTDMO services
By IPP Bureau - October 22, 2021
It’s the company’s fourth manufacturing site worldwide. Others are located in the US, UK and China
Rakuten Medical partners with Karkinos Healthcare to expand novel cancer care in India
By IPP Bureau - October 22, 2021
This strategic collaboration will enable continued innovation in cancer care
Fujifilm AI detects Covid-19 Pneumonia
By IPP Bureau - October 22, 2021
Fujifilm India recently introduced a “Covid-19 Pneumonia Image Analysis Program” that helps in diagnosing chest CT images that helps in findings of Covid-19 pneumonia
